Karyopharm Therapeutics

-$0.31 (-3.53%) As of 6:52 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).

CEO
Richard A. Paulson
Employees
432
Headquarters
Newton, Massachusetts
Founded
2008

KPTI Key Statistics

Market Cap
708.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.05M
High Today
$8.91
Low Today
$8.38
Open Price
$8.77
Volume
566.56K
52 Week High
$18.00
52 Week Low
$7.78

KPTI Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure